Modified Mediterranean Diet Linked to Healthier Aging in Mice and Humans
Research from the University of Southern California indicates that a modified Mediterranean-style diet, characterized by low protein and carefully balanced levels of the amino acid methionine, has significant health benefits for aging mice. This diet not only increased the healthspan, which is the period of life spent in good health, but also reduced body fat and frailty among older mice. The findings were published in the journal Cell Metabolism and were supported by an extensive analysis of dietary and health data from over 200,000 individuals conducted by researchers from USC, the University of Toronto, and Harvard University. The analysis revealed that individuals who adhered to more plant-based eating patterns exhibited lower rates of obesity and Type 2 diabetes. The results suggest that a Mediterranean-inspired 'longevity diet' focused on predominantly vegan or vegetarian foods, supplemented with fish, may offer substantial health advantages. Senior author Valter Longo, who has dedicated years to studying the relationship between nutrition and aging, noted that the diet provides low but sufficient amounts of methionine and other essential amino acids. Longo's previous research has highlighted the benefits of traditional low-protein, plant-centered Mediterranean diets, commonly found in regions of southern Europe known for their high life expectancies. However, these populations also experience significant frailty in older age. To address this, Longo developed a modified longevity diet that includes a small amount of methionine to determine if it could mitigate frailty while retaining the benefits of a plant-focused diet. In the study, researchers fed 20-month-old mice one of four different diets: a standard diet, a Western diet high in fats and sugars, a low-carbohydrate ketogenic diet, or the low-protein, methionine-supplemented longevity diet (LDMM). The mice on the LDMM diet consistently showed the best outcomes, enjoying a longer healthspan, reduced body fat, and fewer signs of frailty compared to those on the other diets. Maura Fanti, a research associate at USC and the study's first author, remarked on the surprising impact of modulating a single amino acid, methionine, which led to significant metabolic changes. The researchers also observed improvements in various biological markers linked to cardiometabolic health in mice consuming the LDMM. These included increased levels of GLP-1 and other signaling molecules that play roles in metabolism and aging across species. While acknowledging the differences in metabolic regulation between mice and humans, Fanti expressed optimism about the potential for similar effects in human studies. Longo pointed out another noteworthy finding: mice on the LDMM consumed more food than those on other diets, yet they lost body fat while maintaining lean muscle mass, a benefit that only emerged with low but adequate methionine levels. The human data analysis echoed these findings, revealing that participants with higher animal protein consumption, and consequently higher methionine levels, had increased obesity rates and were twice as likely to develop Type 2 diabetes compared to those who consumed little or no animal protein. Longo emphasized that these differences persisted even though high animal protein consumers generally had healthier diets and lower calorie intakes. This challenges the prevailing notion that calorie reduction is essential for weight loss, underscoring the need for a deeper understanding of the underlying mechanisms. The research team plans to conduct controlled clinical trials to evaluate the LDMM's effects on human health, aiming to determine if the same benefits observed in mice can be replicated in people. The study involved collaboration among researchers from the USC Leonard Davis School of Gerontology, the University of Toronto, Harvard University, the University of Campinas, the Keck School of Medicine of USC, and Children's Hospital Los Angeles. Funding was provided by the National Institute on Aging and the National Institute of Health, among other sources. Longo has a financial interest in L-Nutra, a company developing medical foods, and has filed patents related to the Fasting-Mimicking Diet through the University of Southern California.




